Siga's financial stability is threatened by potential policy changes, while Emergent's favorable valuation metrics position ...
A recent study presented by Orit Cohen Barak in the ACR Convergence 2024 showed that with the extra advantage of a ...
The FDA has accepted a new drug application for aficamten, a new obstructive hypertrophic cardiomyopathy drug. A goal date ...
Revolution has set itself a mission to revolutionize treatment for patients with RAS addicted cancers. See why I upgrade RVMD ...
Cumberland, Dauphin, and Perry counties have partnered with Connections Health Solutions to launch the first regional ...
Baricitinib is an effective treatment option for children and adolescents with atopic dermatitis, with no new safety signals identified.